MARKET WIRE NEWS
  1. Home
  2. Stock
  3. NGNE
  4. News
NGNE
Quote
Short
News
Articles
Message Board

Neurogene Inc. (NASDAQ : NGNE ) News

News Releases

NGNE News Releases
NGNE : NASDAQ
SeekingAlpha
Neurogene: 'Hold' EMBOLDEN Study Underway And 2nd Half 2027 Topline Data
NGNE : NASDAQ
SeekingAlpha
Neurogene prices $125M equity offering
NGNE : NASDAQ
Business Wire
Neurogene Inc. Announces Pricing of $125 Million Public Offering
NGNE : NASDAQ
SeekingAlpha
Neurogene launches public stock offering
NGNE : NASDAQ
Business Wire
Neurogene Inc. Announces Proposed Public Offering
NGNE : NASDAQ
SeekingAlpha
Neurogene Inc. (NGNE) Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome Transcript
NGNE : NASDAQ
Business Wire
Neurogene Reports Positive Long-term Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome
NGNE : NASDAQ
Business Wire
Neurogene Announces Successful Completion of Dosing in Embolden(TM) Registrational Trial of NGN-401 for Rett Syndrome
NGNE : NASDAQ
SeekingAlpha
Neurogene GAAP EPS of -$1.39 misses by $0.09
NGNE : NASDAQ
Business Wire
Neurogene Reports First Quarter 2026 Financial Results and Highlights Recent Updates
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.